Use of PRG4 to improve dynamic visual acuity and higher order aberrations
Abstract:
Disclosed are methods involving the therapeutic use of human PRG4 (lubricin) protein, to improve vision, to reduce aberrations such as impaired night vision, halos, and glare, to improve the stability of the tear film, and to homogenize the refractive index of the surface of the eye.
Information query
Patent Agency Ranking
0/0